Immunological Dynamics Associated with Direct-Acting Antiviral Therapies in Naive and Experimented HCV Chronic-Infected Patients

• Egile Nagusiak: Grenda Leite Pereira (Egilea), Andréa Monteiro Tarragô (Egilea), Walter Luiz Lima Neves (Egilea), Pedro Vieira da Silva Neto (Egilea), Priscila Sarmento de Souza (Egilea), Juliana dos Santos Affonso (Egilea), Keyla Santos de Sousa (Egilea), Jéssica Albuquerque da Silva (Egilea), Allyson Guimarães Costa (Egilea), Flamir da Silva Victoria (Egilea), Marilu Barbieri Victoria (Egilea), Adriana Malheiro (Egilea)
• Formatua: Liburua
• Argitaratua: Hindawi Limited, 2019-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

The therapeutic strategies used in the treatment of hepatitis C are essentially based on the combination of direct-acting antiviral agents (DAAs). This therapy has been shown to be very effective in relation to patient adherence to treatment and has shown high rates of sustained virological response...